Clinical meaning
Malaria is a life-threatening parasitic disease caused by Plasmodium species and transmitted to humans through the bite of an infected female Anopheles mosquito. Five Plasmodium species cause malaria in humans: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi. Of these, P. falciparum is the most virulent and causes the majority of malaria-related deaths worldwide, while P. vivax is the most geographically widespread. The life cycle of the malaria parasite involves two hosts: the mosquito (definitive host where sexual reproduction occurs) and the human (intermediate host where asexual reproduction occurs). When an infected female Anopheles mosquito bites a human, it injects sporozoites into the bloodstream. These sporozoites travel to the liver within 30 minutes and invade hepatocytes, where they undergo asexual multiplication (exo-erythrocytic schizogony) over 7 to 30 days, producing thousands of merozoites. P. vivax and P. ovale can also form dormant liver stages called hypnozoites, which can reactivate weeks to years later causing relapse -- this is a critical distinction because treatment of P. vivax and P. ovale requires primaquine to eliminate hypnozoites and prevent relapse. The merozoites are released from the liver into the bloodstream, where they invade red blood cells (erythrocytes) and undergo further asexual multiplication (erythrocytic schizogony). Inside the red blood cell, the parasite progresses through ring stage, trophozoite stage, and schizont stage before the red blood cell ruptures, releasing 8 to 32 new merozoites that invade fresh red blood cells, continuing the cycle. The synchronous rupture of infected red blood cells releases merozoites, hemozoin (malaria pigment), and cellular debris into the bloodstream, triggering a massive inflammatory response with release of tumor necrosis factor (TNF), interleukin-1, and other pyrogenic cytokines. This synchronized release produces the characteristic cyclical fevers of malaria: every 48 hours for P. falciparum, P. vivax, and P. ovale (tertian malaria), and every 72 hours for P. malariae (quartan malaria). P. falciparum is uniquely dangerous because infected red blood cells express adhesion molecules (PfEMP1) on their surface that cause them to stick to the endothelium of small blood vessels (cytoadherence) and to uninfected red blood cells (rosetting). This leads to microvascular obstruction, tissue hypoxia, and organ damage. Cerebral malaria occurs when parasitized red blood cells obstruct cerebral microvasculature, causing altered consciousness, seizures, and coma. Other severe manifestations include severe anemia (from massive red blood cell destruction), acute respiratory distress syndrome (ARDS), acute kidney injury, metabolic acidosis, and hypoglycemia (the parasite consumes glucose, and quinine stimulates insulin release).